Filter Results:
(64)
Show Results For
- All HBS Web
(939)
- People (2)
- News (64)
- Research (779)
- Events (1)
- Multimedia (2)
- Faculty Publications (670)
Show Results For
- All HBS Web
(939)
- People (2)
- News (64)
- Research (779)
- Events (1)
- Multimedia (2)
- Faculty Publications (670)
Sort by
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company headquartered in Egypt. The... View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
they know what disruptive innovation means, but I’ve found it’s often misunderstood. The simplest way to describe it — in a way that applies to health care or any industry — is innovation that transforms a product or service that... View Details
- 01 Sep 2006
- News
Gift of Gab
then delivered a prepared talk on a topic of their choice. Subjects ranged from the pharmaceutical industry to the relative merits of cats vs. dogs, while Kim’s presentation took a humorous yet thoughtful... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
Association’s conference held on campus in early November. The three-day conference included presentations by industry executives, government officials, and HBS faculty on topics ranging from trends in the biotech and View Details
- 01 Mar 2003
- News
Inside the Revolution
humanity discovered how to use fire,” says Enriquez’s colleague, HBS associate professor Jonathan West. West, who had been researching the semiconductor industry for some ten years, came to the life sciences field rather recently.... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
aspirations, purpose, and values, so that they work together as an aligned team." Dan Vasella finds that the skills he called upon as a practicing physician are equally useful in running one of the world's largest pharmaceutical... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical View Details
- 01 Dec 2004
- News
Finding a Balance
would otherwise be unable to afford treatment. Authored in 2003 by HBS professor Rohit Deshpandé, the case began as a straight pricing study. “The pharmaceutical industry is unlike any other,” Deshpandé... View Details
- 01 Apr 1999
- News
Q & A: Confronting New Technologies: When Doing Right Is Wrong
industries or certain segments of the pharmaceutical business. But in many other industries - financial services, education, and health care, for instance - this analytical... View Details
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
portfolio of programs in parallel.” In an industry where serial entrepreneurship is the norm, Cytokinetics’s approach instead requires “a strategy based on sustainability and durability” that includes forging significant partnerships with... View Details
Keywords: Deborah Blagg
- 01 Sep 2008
- News
Mara Aspinall
that personalized medicine brings. This is particularly important in fast-moving diseases, where the window for a positive outcome is small. What aspects of their business model do pharmaceutical companies need to redesign to hasten the... View Details
- 11 Aug 2014
- News
The First Five Years: Melissa Fensterstock (MBA 2012)
where we don't speak about business matters—going on a jog together, date night, or work-free vacation. A break is healthy for everyone to recharge, regroup, and reflect." How do you use what you learned at HBS at IMMUNE Pharmaceuticals... View Details
- 01 Jun 2000
- News
The Business of Biotech
is not a postdoc lab, this is a business. It's not enough just to do the experiment; somebody's got to take the ball and run with it." Lately, competition in the biotech industry has become more heated than ever, as a steadily increasing... View Details
Keywords: Julia Hanna
- 01 Jan 2008
- News
Jeffrey R. Immelt, MBA 1982
Jeff Immelt’s night table—Railway Age, Aviation Week, Broadcasting & Cable—represents just a few of the industries encompassed by General Electric, the company founded by Thomas Edison where Immelt is entering his ninth year as chairman... View Details
- 01 Mar 2003
- News
Naina Lal Kidwai
to the global automobile industry. Biotechnology and pharmaceutical firms are emerging as international players. There are also opportunities in infrastructure investment, such as telecom, ports, roads, and airports. Please comment on... View Details
- 01 Dec 2003
- News
The Next Big Thing
life-sciences center of the world, by virtue of its unsurpassed “cluster” of world-renowned universities and teaching hospitals; medical-device, biotech, and pharmaceutical companies; financial firms; and skilled workers. “The leadership... View Details
- 01 Sep 2010
- News
Fair Trade
pharmaceuticals and software, and far above the average of all industries. Many apparent paradoxes add to the puzzle posed by the industry. While rarely considered fundamentally “bad,” such as the trade in narcotics or tobacco, the beauty... View Details
- 01 Dec 2013
- News
Your Own Medicine
help build new muscle—had been one of several potential treatments the Secklers chased to no avail, often stuck following promising science to dead ends. That changed three years ago, when former pharmaceutical executive Gene Williams... View Details
- 01 Feb 2000
- News
Executives Convene to Discuss Consumer-Driven Health Care
available to their workers. The conference's agenda alternated between small breakout sessions that brought together participants from different industry areas and large group discussions where all attendees could compare notes. The... View Details